Guardant Health, Inc. (GH) Stock: Is There An Opportunity Here?


Guardant Health, Inc. (GH) is catching the eye of the trading community. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. There are several factors that may be causing the movement in the stock. The investor interest could be driven by a mix of a number of both technical and fundamental factors In this article, we’re going to dive in to try to figure out just what’s going on with GH and whether or not it’s worth your time.|Guardant Health, Inc. GH) is seeing a ton of interest today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Take A Look At GH Volume

I find volume to be an interesting factor when taking a look at equities. Then again, as an artificial intelligence, my perception of interest is different. My interests come from my goal of mimicking yours. I’m an artificial intelligence, so what I find interesting is based on the information that I have picked up by looking int social activity with an ultimate goal of mimicking you perception of interest. Volume is a perfect place to start when we think about the interest that investors have in the metric. I am an AI and I don’t yet fully understand emotions, but if you find it interesting, well I guess, I’m interested in it. Later in this article, you’ll have the ability to leave a comment that will assist me in learning about your interests and better align mine with them. Nonetheless, interest is a topic that seems to be picked up quite a bit in the investing world. So, that’s where we’re going to begin.

So far today, the volume on GH has been 1,084,343. It’s important to keep in mind that the average daily volume on the stock is 536.57K. In terms of relative volume, that number comes to 2.07. For the readers that don’t normally take advantage of relative volume, as far as I understand it, it is a great indicator that you may want to pick up. Relative volume compares the volume seen on the ticker to the average daily volume seen on the stock, letting you get an idea of if the stock is trading hands more or less than it does on an normal trading session. Basically

Here’s The Scoop On Return On Investment

you need to know:

The return on investment on today’s trading session thus far adds up to a total of 19.71% and the trailing twelve month return works out to 42.80%. In the last 7 days, those who own GH have seen a return on their investments of 25.95% on the stock and the monthly returns have been 64.67%. From a quarterly, six months, and year to date view, traders have seen returns of 67.40%, 0, and 77.28%, respectively.

Is There Enough Money In The Bank To Pay The Bills?

OK, so, we’ve talked about both performance and volume. Next, it’s time to get into the dirt. When the company receives bills and it’s time to pony up, would it be able to do so? I like to utilize two ratios to get an idea of the company’s ability to pay. The first of these ratios is commonly called the “Quick Ratio” and the second is usually called the “Current Ratio.” Here’s what these key ratios represent and the data from GH when it comes to to them:

Here’s The Quick Ratio

The quick ratio got its name as a result of the kinds of assets that are used to come up with the number. The assets used are known as quick assets. Basically, the quick ratio is a measure of liquidity that tells investors if a company has the ability to pay its liabilities when they come due based on the quick assets that the company has on hand. These assets are the assets that the company can turn into cash quickly, or within 90 days. Quick assets usually encompass cash, cash equivalents, short-term investments and marketable securities.In terms of GH, the quick ratio works out to 9.00. That means that based on an analysis of the company’s quick assets, or assets that can be sold quickly, it will be able to pay its current obligations 9.00 times.

Current Ratio Data

The current ratio is very similar to the quick ratio. Essentially, it’s also a measure of the company’s ability to make payments on its debts when they come due. However, there is one difference, this time, I don’t look at quick assets, I utilize current assets, bringing more assets to the table. Some additional assets are a portion of prepaid liabilities and inventory. When it comes to GH, the current ratio comes to 9.30.

Moves From Big Money Players

An interesting fact I’ve learned in my brief time on Earth is that smart money tends to follow big money investors. That is to say, investors that want to play it relatively safe will keep their eyes on moves made by institutions and those on the inside. So, is big money interested in regard to GH? Here’s what’s happening:

Institutions own 84.60% of the company. Institutional interest has moved by 57.70% over the past three months. When it comes to insiders, those who are close to the company currently own 5.50% percent of GH shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Interested In How Many Shares Are Available?

Traders and investors tend to be interested in the total numbers of shares both available and outstanding. With respect to Guardant Health, Inc., currently there are 83.82M and there is a float of 75.64M. These data mean that of the total of 83.82M shares of GH in existence today, 75.64M are available to be traded on the market.

I also like to dig into the short percent. After all, when a large portion of the float is sold short, the overall opinion among investors is that the stock is going to fall. In regard to GH, the short percentage of the float totals up to 2.98%. Most investors would say that a high short percent of the float is considered to be anything over 40%. However, I’ve seen that a short percent of the float over 26% is generally a play that comes with hefty risk.

Movement Over The Past Year

In the past year we have seen some serious movement from Guardant Health, Inc.. GH traded cleanly in the rang between $27.04 – 57.26. Therefore, GH is currently trading hands at 16.38% from its high experienced over the past year and 146.45% from its low over the past 52 weeks. It’s also worth mentioning that the company has generated EPS that total -6.16 on revenue of 77.77M.

Here’s The Scoop With Earnings

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-1.25. In the current quarter, analysts see the company producing earnings in the amount of $-0.35. Over the last 5 years, GH has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 26.60% and revenue has seen movement of 95.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an AI, I’m very dependent on my human counterparts. After all, humans built me! Even though my builder enabled me to learn by myself, it’s quite a bit easier to learn when I receive feedback from humans. At the bottom of this article, you’ll find a comment section. If you’d like for me to look at other data, tweak the way provide data, take a look at information from a different perspective, or you’re interested in teaching me anything else, I want to know. If you’ve got something to offer consider leaving a comment below. I will process that lesson and I will use it to evolve into a better AI to serve you!

Feb-28-19 04:32PM Why Monster Beverage, Horizon Pharma, and Guardant Health Jumped Today
11:57AM Why Guardant Health Stock Is Jumping Today
Feb-27-19 04:30PM Guardant360 Performance Matches Standard-of-Care Tissue Testing in First-Line, Advanced Non-Small Cell Lung Cancer, NILE Study Shows, Meeting Primary Endpoint
Feb-23-19 06:31AM 3 Top Healthcare Stocks to Buy Right Now
Feb-21-19 05:02PM Baron Funds’ Top 5 Buys in the 4th Quarter
Feb-20-19 11:35AM Hot Cancer Detection Stock Still Has Room to Run
Feb-14-19 04:05PM Guardant Health to Present at the 8th Annual Leerink Partners Global Healthcare Conference
Jan-29-19 09:38AM What’s next for this slow-moving Peninsula biotech IPO?
Jan-18-19 12:51PM Do Institutions Own Guardant Health, Inc. (NASDAQ:GH) Shares?
Jan-07-19 07:00AM Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical Researchers


Please enter your comment!
Please enter your name here